table of content
1 Introduction to Research & Analysis Reports
1.1 Cancer Genomic Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Genomic Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Genomic Testing Overall Market Size
2.1 Global Cancer Genomic Testing Market Size: 2022 VS 2029
2.2 Global Cancer Genomic Testing Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Genomic Testing Players in Global Market
3.2 Top Global Cancer Genomic Testing Companies Ranked by Revenue
3.3 Global Cancer Genomic Testing Revenue by Companies
3.4 Top 3 and Top 5 Cancer Genomic Testing Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cancer Genomic Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Genomic Testing Players in Global Market
3.6.1 List of Global Tier 1 Cancer Genomic Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Genomic Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Genomic Testing Market Size Markets, 2022 & 2029
4.1.2 Breast Cancer Genomic Testing
4.1.3 Lung Cancer Genomic Testing
4.1.4 Blood Cancer Genomic Testing
4.1.5 Liver Cancer Genomic Testing
4.1.6 Stomach Cancer Genomic Testing
4.1.7 Others
4.2 By Type - Global Cancer Genomic Testing Revenue & Forecasts
4.2.1 By Type - Global Cancer Genomic Testing Revenue, 2018-2023
4.2.2 By Type - Global Cancer Genomic Testing Revenue, 2024-2029
4.2.3 By Type - Global Cancer Genomic Testing Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Genomic Testing Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Diagnostic Laboratories
5.1.5 Academic and Research Institutes
5.1.6 Others
5.2 By Application - Global Cancer Genomic Testing Revenue & Forecasts
5.2.1 By Application - Global Cancer Genomic Testing Revenue, 2018-2023
5.2.2 By Application - Global Cancer Genomic Testing Revenue, 2024-2029
5.2.3 By Application - Global Cancer Genomic Testing Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Cancer Genomic Testing Market Size, 2022 & 2029
6.2 By Region - Global Cancer Genomic Testing Revenue & Forecasts
6.2.1 By Region - Global Cancer Genomic Testing Revenue, 2018-2023
6.2.2 By Region - Global Cancer Genomic Testing Revenue, 2024-2029
6.2.3 By Region - Global Cancer Genomic Testing Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Cancer Genomic Testing Revenue, 2018-2029
6.3.2 US Cancer Genomic Testing Market Size, 2018-2029
6.3.3 Canada Cancer Genomic Testing Market Size, 2018-2029
6.3.4 Mexico Cancer Genomic Testing Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Cancer Genomic Testing Revenue, 2018-2029
6.4.2 Germany Cancer Genomic Testing Market Size, 2018-2029
6.4.3 France Cancer Genomic Testing Market Size, 2018-2029
6.4.4 U.K. Cancer Genomic Testing Market Size, 2018-2029
6.4.5 Italy Cancer Genomic Testing Market Size, 2018-2029
6.4.6 Russia Cancer Genomic Testing Market Size, 2018-2029
6.4.7 Nordic Countries Cancer Genomic Testing Market Size, 2018-2029
6.4.8 Benelux Cancer Genomic Testing Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Cancer Genomic Testing Revenue, 2018-2029
6.5.2 China Cancer Genomic Testing Market Size, 2018-2029
6.5.3 Japan Cancer Genomic Testing Market Size, 2018-2029
6.5.4 South Korea Cancer Genomic Testing Market Size, 2018-2029
6.5.5 Southeast Asia Cancer Genomic Testing Market Size, 2018-2029
6.5.6 India Cancer Genomic Testing Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Cancer Genomic Testing Revenue, 2018-2029
6.6.2 Brazil Cancer Genomic Testing Market Size, 2018-2029
6.6.3 Argentina Cancer Genomic Testing Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Genomic Testing Revenue, 2018-2029
6.7.2 Turkey Cancer Genomic Testing Market Size, 2018-2029
6.7.3 Israel Cancer Genomic Testing Market Size, 2018-2029
6.7.4 Saudi Arabia Cancer Genomic Testing Market Size, 2018-2029
6.7.5 UAE Cancer Genomic Testing Market Size, 2018-2029
7 Cancer Genomic Testing Companies Profiles
7.1 Myriad Genetics
7.1.1 Myriad Genetics Company Summary
7.1.2 Myriad Genetics Business Overview
7.1.3 Myriad Genetics Cancer Genomic Testing Major Product Offerings
7.1.4 Myriad Genetics Cancer Genomic Testing Revenue in Global Market (2018-2023)
7.1.5 Myriad Genetics Key News & Latest Developments
7.2 Centogene AG
7.2.1 Centogene AG Company Summary
7.2.2 Centogene AG Business Overview
7.2.3 Centogene AG Cancer Genomic Testing Major Product Offerings
7.2.4 Centogene AG Cancer Genomic Testing Revenue in Global Market (2018-2023)
7.2.5 Centogene AG Key News & Latest Developments
7.3 Color Genomics
7.3.1 Color Genomics Company Summary
7.3.2 Color Genomics Business Overview
7.3.3 Color Genomics Cancer Genomic Testing Major Product Offerings
7.3.4 Color Genomics Cancer Genomic Testing Revenue in Global Market (2018-2023)
7.3.5 Color Genomics Key News & Latest Developments
7.4 Quest Diagnostics
7.4.1 Quest Diagnostics Company Summary
7.4.2 Quest Diagnostics Business Overview
7.4.3 Quest Diagnostics Cancer Genomic Testing Major Product Offerings
7.4.4 Quest Diagnostics Cancer Genomic Testing Revenue in Global Market (2018-2023)
7.4.5 Quest Diagnostics Key News & Latest Developments
7.5 23andMe Inc.
7.5.1 23andMe Inc. Company Summary
7.5.2 23andMe Inc. Business Overview
7.5.3 23andMe Inc. Cancer Genomic Testing Major Product Offerings
7.5.4 23andMe Inc. Cancer Genomic Testing Revenue in Global Market (2018-2023)
7.5.5 23andMe Inc. Key News & Latest Developments
7.6 Gene By Gene Ltd.
7.6.1 Gene By Gene Ltd. Company Summary
7.6.2 Gene By Gene Ltd. Business Overview
7.6.3 Gene By Gene Ltd. Cancer Genomic Testing Major Product Offerings
7.6.4 Gene By Gene Ltd. Cancer Genomic Testing Revenue in Global Market (2018-2023)
7.6.5 Gene By Gene Ltd. Key News & Latest Developments
7.7 LabCorp
7.7.1 LabCorp Company Summary
7.7.2 LabCorp Business Overview
7.7.3 LabCorp Cancer Genomic Testing Major Product Offerings
7.7.4 LabCorp Cancer Genomic Testing Revenue in Global Market (2018-2023)
7.7.5 LabCorp Key News & Latest Developments
7.8 Positive Bioscience
7.8.1 Positive Bioscience Company Summary
7.8.2 Positive Bioscience Business Overview
7.8.3 Positive Bioscience Cancer Genomic Testing Major Product Offerings
7.8.4 Positive Bioscience Cancer Genomic Testing Revenue in Global Market (2018-2023)
7.8.5 Positive Bioscience Key News & Latest Developments
7.9 Bio-Rad Laboratories
7.9.1 Bio-Rad Laboratories Company Summary
7.9.2 Bio-Rad Laboratories Business Overview
7.9.3 Bio-Rad Laboratories Cancer Genomic Testing Major Product Offerings
7.9.4 Bio-Rad Laboratories Cancer Genomic Testing Revenue in Global Market (2018-2023)
7.9.5 Bio-Rad Laboratories Key News & Latest Developments
7.10 Illumina, Inc.
7.10.1 Illumina, Inc. Company Summary
7.10.2 Illumina, Inc. Business Overview
7.10.3 Illumina, Inc. Cancer Genomic Testing Major Product Offerings
7.10.4 Illumina, Inc. Cancer Genomic Testing Revenue in Global Market (2018-2023)
7.10.5 Illumina, Inc. Key News & Latest Developments
7.11 Agilent Technologies
7.11.1 Agilent Technologies Company Summary
7.11.2 Agilent Technologies Business Overview
7.11.3 Agilent Technologies Cancer Genomic Testing Major Product Offerings
7.11.4 Agilent Technologies Cancer Genomic Testing Revenue in Global Market (2018-2023)
7.11.5 Agilent Technologies Key News & Latest Developments
7.12 Thermo Fisher Scientific
7.12.1 Thermo Fisher Scientific Company Summary
7.12.2 Thermo Fisher Scientific Business Overview
7.12.3 Thermo Fisher Scientific Cancer Genomic Testing Major Product Offerings
7.12.4 Thermo Fisher Scientific Cancer Genomic Testing Revenue in Global Market (2018-2023)
7.12.5 Thermo Fisher Scientific Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
